Intralesional photocoagulation of subcutaneous congenital vascular disorders

National Institute for Clinical Excellence
Record ID 32004000790
English
Authors' objectives:

This study aims to assess the current evidence on the safety and efficacy of intralesional photocoagulation of subcutaneous congenital vascular disorders.

Authors' recommendations: Guidance 1.1 Current evidence on the safety and efficacy of intralesional photocoagulation of subcutaneous congenital vascular disorders does not appear adequate for this procedure to be used without special arrangements for consent and for audit or research. 1.2 Clinicians wishing to undertake intralesional photocoagulation of subcutaneous congenital vascular disorders should take the following actions. - Inform the clinical governance leads in their Trusts. - Ensure that patients understand the uncertainty about the procedures safety and efficacy and provide them with clear written information. Use of the Institute's Information for the Public is recommended. - Audit and review clinical outcomes of all patients having intralesional photocoagulation of subcutaneous congenital vascular disorders. 1.3 Publication of safety and efficacy outcomes will be useful in reducing the current uncertainty. The Institute is not undertaking further investigation at present.
Authors' methods: Overview
Details
Project Status: Completed
Year Published: 2004
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: England, United Kingdom
MeSH Terms
  • Arteriovenous Malformations
  • Hemangioma
  • Light Coagulation
  • Port-Wine Stain
  • Skin Abnormalities
Contact
Organisation Name: National Institute for Clinical Excellence
Contact Address: MidCity Place, 71 High Holborn, London WC1V 6NA, UK. Tel: +44 020 7067 5800; Fax: +44 020 7067 5801
Contact Name: nice@nice.nhs.uk
Contact Email: nice@nice.nhs.uk
Copyright: National Institute for Clinical Excellence (NICE)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.